Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid-Reference-Cited by-同舟云学术

Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid

Published:2017-10-25 Issue:12 Volume:6 Page:814-822
ISSN:2163-8306
Container-title:CPT: Pharmacometrics & Systems Pharmacology
language:en
Short-container-title:CPT Pharmacometrics Syst. Pharmacol.

Author:

Salerno Sara N.¹,Edginton Andrea²,Cohen-Wolkowiez Michael³⁴,Hornik Christoph P.¹³⁴,Watt Kevin M.³⁴,Jamieson Brian D.⁵,Gonzalez Daniel¹

Affiliation:

1. Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy; The University of North Carolina at Chapel Hill; Chapel Hill North Carolina USA

2. School of Pharmacy; University of Waterloo; Kitchener Ontario Canada

3. Department of Pediatrics; Duke University Medical Center; Durham North Carolina USA

4. Duke Clinical Research Institute, Duke University Medical Center; Durham North Carolina USA

5. Cempra Inc; Chapel Hill North Carolina USA

Funder

Thrasher Research Fund

Eunice Kennedy Shriver National Institute of Child Health and Human Development

Publisher

Wiley

Subject

Pharmacology (medical),Modeling and Simulation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/psp4.12252/fullpdf

Reference41 articles.

1. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections;Felmingham;Clin. Microbiol. Infect.,2002

2. https://resistancemap.cddep.org/AntibioticResistance.php

3. Solithromycin inhibition of protein synthesis and ribosome biogenesis in Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae;Rodgers;Antimicrob. Agents Chemother.,2013

4. Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL);Barrera;Lancet Infect. Dis.,2016

5. SOLITAIRE-IV: a randomized, double-blind, multicenter study comparing the efficacy and safety of intravenous-to-oral solithromycin to intravenous-to-oral moxifloxacin for treatment of community-acquired bacterial pneumonia;File;Clin. Infect. Dis.,2016

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of Empirical Scalars To Enable Early Prediction of Human Hepatic Clearance Using In Vitro-In Vivo Extrapolation in Drug Discovery: An Evaluation of 173 Drugs;Drug Metabolism and Disposition;2022-05-30

2. Authors’ Reply to De Sutter, De Waele, and Vermeulen: “Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update”;Clinical Pharmacokinetics;2022-01-04

3. Penetration of Antibacterial Agents into Pulmonary Epithelial Lining Fluid: An Update;Clinical Pharmacokinetics;2021-10-15

4. Leveraging Physiologically Based Pharmacokinetic Modeling and Experimental Data to Guide Dosing Modification of CYP3A-Mediated Drug-Drug Interactions in the Pediatric Population;Drug Metabolism and Disposition;2021-06-21

5. Comparison of solithromycin with erythromycin in Enterococcus faecalis and Enterococcus faecium from China: antibacterial activity, clonality, resistance mechanism, and inhibition of biofilm formation;The Journal of Antibiotics;2020-10-19